Benjamin F. Edwards & Company, Inc. Glaukos Corp Transaction History
Benjamin F. Edwards & Company, Inc.
- $5.69 Billion
- Q2 2024
A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Glaukos Corp stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 198 shares of GKOS stock, worth $20,463. This represents 0.0% of its overall portfolio holdings.
Number of Shares
198
Previous 49
304.08%
Holding current value
$20,463
Previous $5,000
360.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding GKOS
# of Institutions
355Shares Held
50.1MCall Options Held
282KPut Options Held
401K-
Black Rock Inc. New York, NY8.04MShares$831 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.97MShares$618 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA2.16MShares$223 Million0.06% of portfolio
-
State Street Corp Boston, MA2.06MShares$213 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.93MShares$200 Million0.08% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $4.92B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...